Haapaniemi et al address the issues raised by Brown et al and discuss several differences between the analyses performed by the two groups.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686827 | PMC |
| http://dx.doi.org/10.15252/msb.20199059 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pioneering the future: CRISPR-Cas9 gene therapy for hereditary hemorrhagic telangiectasia. Author's reply.
Eur J Intern Med
September 2024
HHT Unit. Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat, Barcelona, Spain; Internal Medicine Department. Hospital Universitari de Bellvitge. L'Hospitalet de Llobregat, Barcelona, Spain; Bellvitge Biomedical Research Institute (IDIBELL). L'Hospitalet de Llobregat, Barcelona, Spain; Faculty of Medicine and Health Sciences. Universitat de Barcelona, Barcelona Spain. Electronic address:
Evaluating the effect of bempedoic acid on kidney function: call for cautious implementation - Authors' reply.
Lancet Diabetes Endocrinol
April 2024
Cleveland Clinic, Cleveland, OH, USA.
Genome editing of human embryos for research purposes: Japanese lay and expert attitudes.
Front Genet
June 2023
Uehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Multiple surveys of the general public and experts on human genome editing have been conducted. However, many focused only on editing in clinical applications, with few regarding its use for basic research. Given that genome editing for research purposes is indispensable for the realization of clinical genome editing, understanding lay attitudes toward genome editing in research, particularly using human embryos, which is likely to provoke ethical concerns, is helpful for future societal discussion.
View Article and Find Full Text PDFCRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis. Reply.
N Engl J Med
October 2021
Intellia Therapeutics, Cambridge, MA.
Reply to Fabre et al. Comment on "Tanmoy et al. CRISPR-Cas Diversity in Clinical Serovar Typhi Isolates from South Asian Countries. 2020, , 1365".
Genes (Basel)
July 2021
Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.
We respectfully thank Fabre et al. [..
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!